n!Biomachines
n!Biomachines Ltd., a subsidiary of The Cultivated B GmbH, develops and manufactures fit-for-purpose AUXO V® bioreactors spanning benchtop to industrial scale (up to 25,000L) for the food, supplement, and cosmetics industries, alongside supporting automation and real-time monitoring software.
- Company typePrivate
- Founded2021
- HeadquartersBurlington, Canada
- Headcount11–50
- GTM typeB2B
- OfferingHardware or Manufacturing
What n!Biomachines does
n!Biomachines Ltd. is a Burlington, Ontario-based biotechnology company—wholly owned by German parent The Cultivated B GmbH—that develops and manufactures fit-for-purpose bioreactors under the AUXO V® brand for next-generation bioprocessing. Founded in 2021 and operating with 11–50 employees, the company targets the food, supplement, and cosmetics industries rather than pharmaceutical applications, positioning its hardware as a lower-cost, purpose-built alternative to incumbent pharma-grade systems.
Its product portfolio spans three scale tiers—AUXO V® Benchtop, Pilot-Scale, and Industrial-Scale bioreactors (up to 25,000L)—supported by dedicated software for advanced automation and real-time on-site and remote monitoring. Core differentiators include fit-for-purpose engineering for specific biological processes and host organisms (cell, microbial, algae), modular cultivation design, and a design philosophy that strips 'superfluous features' to reduce capital and operating costs. The AUXO V bioreactor earned a 2024 Red Dot Design Award.
Commercially, n!Biomachines runs a dual go-to-market: a sales-led motion targeting enterprise and industrial buyers through website CTAs ('Configure your biomachine', 'Meet an expert') with multi-year contracts on industrial-scale systems, alongside a product-led/self-service channel for benchtop and pilot customers. Revenue comes from bioreactor hardware sales, customization/configuration, and support services. Recent strategic activity—MOUs with the Weizmann Institute of Science (Nov 2025) and Lambton College (May 2025), and entry into the NVIDIA Connect Program (2025)—signals ecosystem-building around scientific validation and AI-enabled bioprocessing, though no financial scale signals (revenue, funding, headcount growth) are disclosed.
n!Biomachines firmographics
Firmographics- Name
- n!Biomachines
- Legal name
- n!Biomachines Ltd.
- Website
- https://thecultivatedb.ca
- Company type
- Private
- Founded year
- 2021
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Short description
- n!Biomachines Ltd., a subsidiary of The Cultivated B GmbH, develops and manufactures fit-for-purpose AUXO V® bioreactors spanning benchtop to industrial scale (up to 25,000L) for the food, supplement, and cosmetics industries, alongside supporting automation and real-time monitoring software.
- Ownership category
- akta.pro rank
n!Biomachines industry classification
Industry- Product category
- Bioprocessing Equipment
- NAICS
- Analytical Laboratory Instrument Manufacturing (334516)
- SIC
- Industrial Instruments For Measurement, Display, And Control (3823)
- akta.pro primary industry
- Upstream Bioprocessing Systems & Equipment (cell culture/fermentation, bioreactors, feeds/media) (HLAAAJAA)
- akta.pro secondary industries
- Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers) (HLAGAIAG), Automation, Controls & Manufacturing Execution for Bioprocessing (SCADA/DCS/PLC/MES) (HLAAAJAE)
Keywords
Where n!Biomachines is headquartered
LocationHeadquarters
- HQ city
- Burlington
- HQ country
- Canada
- HQ region
- North America
Offices1 record
Markets served
n!Biomachines business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Supply Chain, Technology or R&D, Personnel, Operations, Marketing or Sales, Infrastructure
Revenue model
- Bioreactor Hardware Sales: Sale of fit-for-purpose bioreactor systems across benchtop, pilot-scale, and industrial-scale configurations. Hardware includes AUXO V® bioreactors tailored to specific biological processes and customer requirements.
- Support & Services: Technical support, maintenance, and services for bioreactor systems including Bioengineering hub services.
- Customization & Configuration: Tailored bioreactor solutions engineered to meet specific customer requirements for different types of bioprocesses or host organisms.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Other | Multi-year contract | Industrial-scale bioreactors for large-scale production |
Go-to-market motion2 records
Distribution channels2 records
Marketing channels4 records
n!Biomachines product offering
Product offeringCore offering
n!Biomachines develops and manufactures fit-for-purpose AUXO V® bioreactor systems for next-generation bioprocessing, available in benchtop, pilot-scale, and industrial-scale configurations up to 25,000 liters. The company provides proprietary software for advanced automation and real-time monitoring, along with support services and a bioengineering hub, targeting the food, supplement, and cosmetics industries with affordable, scalable, and modular solutions tailored to specific biological processes and host organisms.
Product overview
n!Biomachines is a subsidiary of The Cultivated B that develops and manufactures fit-for-purpose bioreactors under the AUXO V® brand. The product portfolio consists of three core bioreactor lines—Benchtop, Pilot-Scale, and Industrial-Scale—along with supporting software solutions. The AUXO V® bioreactors are designed for specific biological processes and organisms, targeting the food, supplement, and cosmetics industries. The bioreactors offer scalability from laboratory scale up to 25,000L, with features including modularity for different cultivation types (cell, microbial, algae), advanced automation, real-time monitoring, and a focus on affordability and sustainability.
Differentiator
Problem solved
Functional benefit
Brands
- AUXO V®: Fit-for-purpose bioreactor product line designed and engineered to meet specific requirements of biological processes for different cell types, hosts, and products. Available in benchtop, pilot-scale, and industrial-scale configurations.
Products and services
- AUXO V® Benchtop Bioreactors
Quantifiable outcome
- Scalable production from benchtop to industrial scale up to 25,000L
Companies that use n!Biomachines
Customer profileSegments4 records
Ideal customer profiles4 records
n!Biomachines technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
n!Biomachines partnerships and signals
Strategic signalPartnerships
Three partnerships are on record, tiered core and flagship.
- Weizmann Institute of SciencecoreEntered a Memorandum of Understanding (MOU) to validate and advance the functionality of n!Biomachines' next-generation bioreactor systems. The partnership focuses on scientific validation of bioreactor technology for bioprocessing applications.
- Lambton CollegecoreSigned MOU to advance cellular agriculture innovation in Canada. Partnership marks beginning of collaborative effort to advance the field of cellular agriculture, with n!Biomachines providing bioreactor technology and expertise.
- NVIDIA (NVIDIA Connect Program)flagshipn!Biomachines joined the NVIDIA Connect Program as part of their mission to enable smarter biomanufacturing. The partnership represents a significant step forward in AI-enabled bioprocessing capabilities.
Scale indicators2 records
Recent moves6 records
Expansion highlights5 records
n!Biomachines competitors and assessment
Company assessmentDirect peers
- Sartorius AG: Global leader in bioprocess solutions, including bioreactors for cell culture and microbial fermentation. Directly competes with n!Biomachines in bioprocess equipment, though Sartorius is heavily focused on pharmaceutical applications where n!Biomachines' fit-for-purpose food-grade positioning differentiates.
- PBS Biotech: Specializes in single-use bioreactors for cell therapy, regenerative medicine, and cell culture applications. Direct peer in scalable single-use bioreactor hardware, with comparable modularity and customization features.
- ABEC Inc. Custom-engineered bioreactor and fermentation systems provider serving cell therapy, vaccines, and biotech manufacturing. Direct peer in custom large-scale bioreactor engineering, with growing overlap in cellular agriculture and food-grade bioprocessing.
- Cytiva (Danaher): Supplies bioreactor systems, single-use technologies, and process development tools across the bioprocess workflow. Competes head-on with AUXO V® in scalable bioreactor hardware, particularly for customers moving from process development to manufacturing.
- Applikon Biotechnology (Getinge): Specialist bioreactor manufacturer (now part of Getinge) with benchtop, pilot, and production-scale systems for life sciences and food applications. Direct peer across the full AUXO V® product range.
- Solaris Biotech (Donaldson Company): Designs and manufactures stirred-tank bioreactors and fermenters for industrial biotechnology, with strength in food, beverage, and industrial biotech. Closely comparable on fit-for-purpose positioning for non-pharma bioprocess applications.
- Eppendorf AG: Manufacturer of benchtop and pilot-scale bioreactors (e.g., BioFlo series) used in academic and industrial bioprocessing. Direct competitor in laboratory and pilot-scale bioreactor segments, with overlap in academic and startup customer segments.
Broad incumbents
- Thermo Fisher Scientific: Diversified life sciences incumbent offering bioreactor systems (e.g., HyPerforma) as part of a much broader portfolio spanning instruments, consumables, and services. A potential competitor and potential acquirer as it extends into food-grade bioprocessing.
- Ginkgo Bioworks: Horizontal platform for cell programming and biomanufacturing, with growing infrastructure for cultivated meat and precision fermentation customers. A potential partner or competitor in cellular agriculture bioprocess development.
Emerging players
- Culture Biosciences: Cloud-based bioprocess development platform offering remote-operated bioreactor access and data analytics. Adjacent emerging player that combines bioreactor access with software — a model relevant to n!Biomachines' NVIDIA-enabled smart-manufacturing roadmap.
Market position
Strengths5 records
Weaknesses5 records
Competitive moat4 records
Key risks6 records
Key highlights7 records
Customer concentration
n!Biomachines social profiles
Digital presencen!Biomachines financial estimates
Financial estimateRevenue estimate
Valuation estimate
n!Biomachines leadership team
Management profileNumber of profiles
n!Biomachines funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
n!Biomachines M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about n!Biomachines
What does n!Biomachines do?
n!Biomachines develops and manufactures fit-for-purpose AUXO V® bioreactor systems for next-generation bioprocessing, available in benchtop, pilot-scale, and industrial-scale configurations up to 25,000 liters. The company provides proprietary software for advanced automation and real-time monitoring, along with support services and a bioengineering hub, targeting the food, supplement, and cosmetics industries with affordable, scalable, and modular solutions tailored to specific biological processes and host organisms.
Is n!Biomachines a public or private company?
n!Biomachines is a private company. It is classified as corporate owned and is currently operating.
When was n!Biomachines founded?
n!Biomachines was founded in 2021. It employs 11 to 50 people.
Where is n!Biomachines based?
n!Biomachines is headquartered in Burlington, Canada, in the North America region.
How does n!Biomachines make money?
Three revenue lines are on record. Bioreactor Hardware Sales are the primary driver. The others are support & Services and customization & Configuration.
Who are n!Biomachines's main competitors?
Direct peers on record are Sartorius AG, PBS Biotech, ABEC Inc., Cytiva (Danaher), Applikon Biotechnology (Getinge), Solaris Biotech (Donaldson Company) and Eppendorf AG. Broad incumbents are Thermo Fisher Scientific and Ginkgo Bioworks. Culture Biosciences is listed as an emerging player.
Does n!Biomachines have an API?
No public API is recorded for n!Biomachines.
What industry is n!Biomachines in?
n!Biomachines's product category is Bioprocessing Equipment. Its primary akta.pro industry code is HLAAAJAA, Upstream Bioprocessing Systems & Equipment (cell culture/fermentation, bioreactors, feeds/media), with a secondary code of HLAGAIAG, Cell Culture & Bioprocess Lab Equipment (Bioreactors, Single-Use Systems, Controllers). Its NAICS code is 334516 and its SIC code is 3823.